Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-058-5 | CAS number: 298-12-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.4 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 37.5
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
- The available data on irritation allow only a qualitative assessment of irritation/corrosion following acute exposure. No experimental data are available addressing local effects in the repsiratory tract.
- There have been several proposals made during the last years how to perform a quantitative assessment for sensitisation based on the LLNA’s EC3 value. However, at present there is no common agreement on the assessment factors to be used for a quantitative assessment. Thus, the regulatory acceptance of a proposed DNEL would be highly questionable.
Acute/short term exposure – systemic effects
According to ECHA Guidance on information requirements and CSR, chapter R8, a DNEL for acute systemic toxicity should be derived only if an acute systemic toxicity hazard leading to C & L has been identified.
Glyoxylic Acid 50% has a low acute toxicity as indicated by the LD50 values of 2528 mg/kg bw and > 2000 mg/kg bw determined in rats for oral and dermal exposure, respectively. Therefore, Glyoxylic Acid 50% is not subject to classification and labelling and consequently the establishment of DNELs for acute/short-term exposure - systemic effects is not required.
Acute/short term and long term exposure – local effects
Glyoxylic Acid 50% caused only minimal skin irritation reactions in the rabbit without any relevance for classification and labelling, but was severely eye irritating in the rabbit. Data on respiratory irritation are not available. In the LLNA Glyoxylic Acid 50% was sensitising. Below, local effects following acute/short term or long term exposure were assessed qualitatively. A quantitative assessment was not performed because of the following:
Glyoxylic Acid 50% is classified and labelled with R41 (Risk of serious damage to eyes) and R43 (may cause sensitisation by skin contact) or Cat 1 / H 318 (causes serious eye damage) and Cat 1 / H317 (may cause an allergic skin reaction) according to Directive 67/548/EEC or Regulation 1272/2008/EC, respectively. The calculated EC3 value of 5.05 % indicates a moderate skin sensitisation potential.
Based on these data, Glyoxylic Acid 50% is allocated to the moderate hazard category. The operation conditions and risk management measures indicated in the respective IUCLID 5 and CSR chapters are appropriate and sufficient for controlling the risks.
Long term exposure - systemic effects
In a combined repeated dose toxicity study with the reproduction / developmental toxicity screening according to OECD TG 422 Glyoxylic acid 50% was given to male and female rats at dietary concentrations of 0, 2000, 6000 or 18000 ppm for a period of 5 weeks. The reduced male body weight gain at 18000 ppm reaching periodically statistical significance in comparison to control males was the only adverse effect seen. Based on this result a NOAEL of 6000 ppm corresponding to 200 mg/kg bw/d in males was derived.
Subchronic to chronic dose toxicity or specific reproduction dose toxicity studies (i.e. one or two generation reproduction toxicity and teratogenicity study) of Glyoxylic Acid 50% are not available. However, there is extensive information on ethylene glycol and glyoxal available, which can be used for the assessment of the long term and reproduction toxicity potential of Glyoxylic Acid 50% because Glyoxylic Acid plays a central role in the metabolism of both substances. Data on glyoxal have been given preference over data on ethylene glycol because much less metabolic transformation steps are needed for its conversion into Glyoxylic Acid than for the conversion of ethylene glycol. The available information shows that Glyoxylic Acid 50% does not adversely influence fertility and has no developmental/teratogenic toxicity potential. It also demonstrates that reduced body weight is the most sensitive or among the most sensitive effects following long term administration and that there is no specific target organ toxicity at dose levels relevant for classification, confirming the results obtained in the OECD 422 study with Glyoxylic Acid 50%. Futhermore, it became obvious, that the long term NOAEL does not decrease with increasing exposure time.
From studies on oral exposure of glyoxal, the NOAEL seems to be about 100 mg/kg body weight per day (adjusted to 100% glyoxal). The short- and medium-term studies seem to have similar outcomes, with no evidence of systemic effects, suggesting that exogenous glyoxal is efficiently detoxified and does not accumulate in the body.
As the DNELs obtained with the subacute NOAEL with glyoxylic acid are equivalent but a bit more conservative than with the subchronic NOAEL obtained with glyoxal, it is taken as starting point for the DNEL derivations:
Critical subacute NOAEL = 200 mg pure glyoxylic acid/kg bw/d.
No adequate experimental data are available on dermal or inhalation exposure with regard to systemic effects, thus route-to-route extrapolation based on the oral NOAEL of 200 mg/kg bw/d is the only alternative finding a dose descriptor as starting point for the derivation of the respective DNEL.
Glyoxylic Acid 50% has a low molecular weight (74.04 g/mol) and log Pow (-0.7). It is highly water soluble without a significant dermal irritation potential and is more than 99 % ionised at pH values above 5 (pKa = 3.1). These substance properties show, that absorption after inhalation exposure is lower than or comparable to oral absorption. In contrast, penetration through the lipid rich environment of the stratum corneum is very restricted, so that dermal absorption is significantly lower than oral absorption. This is also supported by the available acute toxicity data, where clinical signs and mortality were seen in rats after oral administration but not after dermal administration of 2000 mg/kg bw. For extrapolation from the oral to dermal exposure route it is conservatively assumed that dermal absorption is three times less than oral absorption, whereas for extrapolation from the oral to inhalation route comparable absorption is assumed.
The resulting corrected dermal NOAEL is then 600 mg/kg bw/d (oral DNEL of 200 mg/kg bw/d x 3).
For the calculation of the corrected inhalation NOAEC the standard breathing volume for the rat of 0.38 m³/kg (8 hours) and the correction factor for the difference between basal caloric demand and caloric demand under light activity have to be taken into account. The latter correction factor derives from the inhalation volume in 8 hours under the respective conditions (6.7 m³ for base level, 10 m³ for light activity). Accordingly, the corrected inhalation NOAEC is 200 mg/kg bw/d / 0.38 m³/kg bw x 6.7 m³ / 10 m³ = 352.6 mg/m³.
- Derivation of dermal DNEL for long-term exposure - systemic effects
The following assessment factors are used for the derivation of the long-term DNEL for dermal exposure:
inter-species factor: 4 (allometric scaling) and 2.5 (additional factor)
intra-species factor (worker): 5
exposure duration factor (subacute to chronic): 3.
The reduced duration assessment factor is justified by the finding, that the oral NOAEL does not decrease with increasing exposure time. Moreover, a recent evaluation of a data base consisting of more than 6000 repeated dose endpoints showed that the subacute to subchronic factor was rather 1.5 than 3 (Bitsch et al., 2006), additionally justifying the reduction of the default assessment factor from 6 to 3.
Based on the corrected dermal NOAEL of 200 mg/kg bw/d the dermal DNEL for long-term exposure - systemic effects is calculated as follows:
600 mg/ kg bw/d / (4 x 2.5 x 5 x 3) = 4 mg/kg bw/day
- Derivation of inhalation DNEL for long-term exposure - systemic effects
The following assessment factors are used for the derivation of the long-term DNEL for inhalation exposure:
inter-species factor: 2.5 (additional factor)
intra-species factor (worker): 5
exposure duration factor (subacute to chronic): 3 (justification as given above)
Based on the corrected inhalation NOAEC of 352.6 mg/m³ the inhalation DNEL for long-term exposure - systemic effects is calculated as follows:
352.6 mg/m³ / (2.5 x 5 x 3) = 9.4 mg/m³
Reference
Bitsch A et al. (2006). REPDOSE: a database on repeated dose toxcity studies of commmercial chemicals - amultifunctional tool. Reg. Tox. Pharmacol. 46, 202 -210.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Additional information - General Population
There is no intended use of Glyoxylic acid 50% in consumer products. Thus, DNELs for the general population do not need to be established according to the REACH legislation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.